argus

Orchid Pharma Limited

NSE: ORCHPHARMAINE191A010274,760 Cr

Timeline

Time (IST)TypeMEventSrc
14 May, 04:52 pmMonitoring Agency Report for Quarter - IV of financial year 2025-26, ended on March 31, 2026nse
14 May, 04:28 pmOrchid Pharma Ltd - 524372 - Announcement under Regulation 30 (LODR)-Monitoring Agency Reportbse
05 May, 11:03 amDHANUKA Laboratories Ltd  has Submitted to the Exchange a copy of Disclosure under Regulation 31(4) of the Securities and Exchange Board of India (Substantial Acquisition of Shares and Takeovers) Regulations, 2011.nse
11 Apr, 05:38 pmOrchid Pharma Ltd - 524372 - Intimation Under Regulation 30bse
11 Apr, 05:34 pmOrchid Pharma Limited has informed the Exchange about Action(s) taken or orders passednse
07 Apr, 06:18 pmOrchid Pharma Limited has informed the Exchange regarding 'Investor Roadshow scheduled to be held on April 10, 2026'.nse
02 Apr, 03:51 pmOrchid Pharma Ltd - 524372 - Announcement under Regulation 30 (LODR)-Credit Ratingbse
02 Apr, 03:50 pmOrchid Pharma Limited has informed the Exchange about Credit Rating- Revisionnse
18 Mar, 09:33 pmOrchid Pharma Limited has informed the Exchange regarding 'Update on Scheme of arrangement'.nse
18 Mar, 09:17 pmOrchid Pharma Ltd - 524372 - Update Related To The Scheme Of Amalgamation Of Dhanuka Laboratories Limited (''Amalgamating Company'') With Orchid Pharma Limited (''Amalgamated Company'') And Their Respective Shareholders And Creditors (''The Scheme'') Under Regulation 30 Of SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015bse
16 Feb, 05:59 pmOrchid Pharma Limited has informed the Exchange about Transcriptnse
16 Feb, 05:57 pmOrchid Pharma Ltd - 524372 - Announcement under Regulation 30 (LODR)-Earnings Call Transcriptbse
12 Feb, 06:33 pmOrchid Pharma Limited has informed the Exchange about Link of Recordingnse
12 Feb, 06:32 pmOrchid Pharma Ltd - 524372 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcomebse
11 Feb, 07:34 pmOrchid Pharma Ltd - 524372 - Announcement under Regulation 30 (LODR)-Monitoring Agency Reportbse
11 Feb, 07:32 pmMonitoring Agency Report for the Quarter-III ended on December 31, 2025nse
11 Feb, 07:28 pmOrchid Pharma Ltd - 524372 - Announcement under Regulation 30 (LODR)-Investor Presentationbse
11 Feb, 07:13 pmOrchid Pharma Limited has informed the Exchange about Presentationnse
11 Feb, 05:48 pmOrchid Pharma Ltd - 524372 - Board Meeting Outcome for Unaudited Limited Review Standalone & Consolidated Financial Results For The Quarter And Year To Date Ended On December 31, 2025bse
11 Feb, 05:46 pmOrchid Pharma Limited has informed the Exchange regarding outcome of the Board meeting held on February 11, 2026.nse
11 Feb, 05:43 pmOrchid Pharma Ltd - 524372 - Quarterly Resultsbse
11 Feb, 05:42 pmOrchid Pharma Limited has submitted to the Exchange, the financial results for the period ended December 31, 2025.nse
06 Feb, 02:37 pmOrchid Pharma Ltd - 524372 - Board Meeting Intimation for The Quarter-III Of Financial Year 2025-26, Ended On December 2025.bse
17 Nov, 04:06 pmOrchid Pharma Limited has informed the Exchange about Transcriptnse
17 Nov, 04:05 pmOrchid Pharma Ltd - 524372 - Announcement under Regulation 30 (LODR)-Earnings Call Transcriptbse
13 Nov, 01:14 pmMonitoring Agency Report for the Quarter-II of F.Y. 2025-26, ended on September 30, 2025- Qrchid Pharma Limitednse
13 Nov, 01:13 pmOrchid Pharma Ltd - 524372 - Announcement under Regulation 30 (LODR)-Monitoring Agency Reportbse
11 Nov, 07:23 pmOrchid Pharma Ltd - 524372 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcomebse
11 Nov, 07:22 pmOrchid Pharma Limited has informed the Exchange about Link of Recordingnse
11 Nov, 03:37 pmOrchid Pharma Ltd - 524372 - Announcement under Regulation 30 (LODR)-Investor Presentationbse
11 Nov, 03:31 pmOrchid Pharma Limited has informed the Exchange about Investor Presentationnse
11 Nov, 03:28 pmOrchid Pharma Ltd - 524372 - Unaudited Limited Reviewed Financial Results For Q-2 Of F.Y.2025-26bse
11 Nov, 03:21 pmOrchid Pharma Ltd - 524372 - Board Meeting Outcome for Outcome Of Board Meeting- Q2- F.Y.2025-26bse
11 Nov, 03:20 pmOrchid Pharma Limited has submitted to the Exchange, the financial results for the period ended September 30, 2025.nse
05 Nov, 12:20 pmOrchid Pharma Ltd - 524372 - Board Meeting Intimation for Prior Intimation Of Board Meeting Scheduled To Be Held On November 11, 2025bse
04 Nov, 12:34 pmSignificant increase in volume has been observed in Orchid Pharma Limited. The Exchange, in order to ensure that investors have latest relevant information about the company and to inform the market place so that the interest of the investors is safeguarded, had written to the company. Orchid Pharma Limited has submitted their response.nse
04 Nov, 11:19 amOrchid Pharma Ltd - 524372 - Clarification sought from Orchid Pharma Ltdbse
03 Nov, 06:28 pmSignificant increase in volume has been observed in Orchid Pharma Limited. The Exchange, in order to ensure that investors have latest relevant information about the company and to inform the market place so that the interest of the investors is safeguarded, has written to the company. The response from the company is awaited.nse
30 Oct, 05:16 pmOrchid Pharma Limited has informed the Exchange about Update on purchase of Assets of Allecra Therapeutics GmbHnse
20 Sept, 05:39 pmOrchid Pharma Ltd - 524372 - Announcement under Regulation 30 (LODR)-Meeting Updatesbse
11 Sept, 11:56 amOrchid Pharma Limited has informed the Exchange regarding Corrigendum to Notice of Annual General Meetingnse